Avitide is dedicated to advancing our partners clinical pipelines and commercial manufacturing processes with a rapid, exclusive, and enabling affinity purification platform technology.

A NEW STANDARD IN SPEED.
Avitide’s industry-leading 3-month service and proprietary affinity resin discovery and development technology offers unparalleled speed, performance, and product resolution that will enable bioprocess programs to define a cost-effective affinity purification solution for any class of biopharmaceutical.

A NEW STANDARD IN PRODUCT QUALITY, YIELD, AND PURITY.
On-demand, molecule-specific affinity purification enables high yield and high purity purification processes for gene therapy vectors, vaccines, bispecific antibodies, and therapeutic
proteins. Let’s move beyond capture: Avitide delivers novel affinity resins that can select for product quality attributes to improve upon drug product purity, safety, and potency.

BIOPROCESS-READY AFFINITY PURIFICATION PERFORMANCE.
Avitide affinity resins are more cost-effective and scalable compared to other affinity ligand and resin manufacturing technologies. The proprietary peptide-based affinity ligands and scaffolds deliver high dynamic binding capacity and cleaning/sanitization stability. To ensure line of sight to commercial resin, affinity ligand manufacturability is assessed very early in the affinity resin discovery and development process (usually within 6 weeks) so that every affinity purification solution delivered is ready to meet the rigors of biopharmaceutical manufacturing.